Dual bronchodilation for the treatment of COPD: From bench to bedside-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual bronchodilation for the treatment of COPD: From bench to bedside

Published:2022-05-25 Issue:8 Volume:88 Page:3657-3673
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Cazzola Mario¹^ORCID,Page Clive²^ORCID,Rogliani Paola¹^ORCID,Calzetta Luigino³^ORCID,Matera Maria Gabriella⁴^ORCID

Affiliation:

1. Unit of Respiratory Medicine, Department of Experimental Medicine University of Rome Tor Vergata Rome Italy

2. Sackler Institute of Pulmonary Pharmacology King's College London UK

3. Unit of Respiratory Diseases and Lung Function, Department of Medicine and Surgery University of Parma Parma Italy

4. Unit of Pharmacology, Department of Experimental Medicine University of Campania Luigi Vanvitelli Naples Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15390

Reference103 articles.

1. Disease severity and symptoms among patients receiving monotherapy for COPD

2. Bronchodilators

3. Pharmacology and Therapeutics of Bronchodilators

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinician’s guide to single vs multiple inhaler therapy for COPD;Expert Review of Respiratory Medicine;2024-07-02

2. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023;Lung;2024-02-06

3. Dual Broncodilator and Triple Therapy in Bronchiectasis. Clinical Trials are Urgently Needed;Archivos de Bronconeumología;2023-12

4. Overuse of long-acting β ₂ -agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns;Postgraduate Medicine;2023-11-17

5. Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update;Expert Opinion on Pharmacotherapy;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3